Leading Oncologist for Lung tumors
Position: Senior Doctor of Lung Oncology Department, Head of Research Laboratory
Hospital: Sheba Medical Center, Tel Hashomer, Israel
Professor Yair Bar is in the Forbes magazine’s list of the Best Doctors in Israel
Prof. Yair Bar is a expert oncologist and head of the lung tumor unit at the cancer center. At the same time as his clinical work, he serves as a principal investigator in many studies in the field of lung cancer in Sheba and initiates and develops new clinical studies. He also manages a translational research laboratory that focuses on the development of experimental models for immunotherapy treatments and research to predict the metastatic spread of lung cancer. He also established and manages the cancer center’s information laboratory, based on automatic collection and processing of clinical data of oncology patients, drawing conclusions through machine learning about the effectiveness of new treatments, and more. In addition, he is involved in teaching interns and students at the Sheba Oncology Institute and was also involved in the subspecialty in Canada, and author of many articles and chapters in medical books.
Qualified Medical Consultation Online, Second Opinion
Private Medical Consultation and Second Opinion
- Lung Cancer – Early and Metastatic Stages
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Lung Nodules
- Mesothelioma
Send Your Medical Files Book Consultation Now
Professional Experience of Prof. Yair Bar
- Senior Oncologist, Lung Oncology Department, Sheba Medical Center, Tel Hashomer, Israel
- Leading Researcher in a translational research laboratory for lung immunotherapy, Sheba Medical Center, Tel Hashomer, Israel
- Clinical Oncologist in oncology treatment and radiotherapy, Sheba Medical Center, Tel Hashomer, Israel
- Lung and thorax Tumors Department, The Ottawa Hospital Cancer Center, Ottawa, Canada
Education and Academic Experience of Prof. Bar
- 2020 Associate Professor of Oncology, Tel Aviv University
- 2015 Senior Lecturer, Faculty of Medicine, Tel Aviv University
- 2014-2015 Responsible for the intern program at the Oncology Institute, Sheba Medical Center, Tel Hashomer
- 2009-2011 Subspecialty in lung tumors, The Ottawa Hospital Cancer Center, Ottawa, Canada
- 2004-2009 Specialization in medical oncology and radiotherapy, Sheba Medical Center, Tel Hashomer
- 2004 PhD in molecular biology in the field of cancer research, Weizmann Institute of Science, Rehovot
- 1998-2000 Research Associate, Weizmann Institute of Science, Rehovot
- 1997 MD graduation in medicine, Hebrew University, Jerusalem
Professional Associations
- 2023-present Member of the Professional Development and Continuing Education Committee, International Association for the Study of Cancer (IASLC)
- 2021-present Member of the European Group for Thoracic Tumors (ETOP)
- 2019-present Founding member of the Lung Ambition Israel group – a consortium of academic and pharmaceutical representatives whose goal is to eradicate lung cancer as a cause of death
- 2015-2020 Chairman of the examination committee for interns of the Scientific Council in Israel in the field of breast tumors
- 2013-2021 Founder and chairman of the Israeli Lung Cancer Society
Awards and achievements
- 2022 Research grant for research cooperation between Israel and Sweden on behalf of Lis Meitner Grants
- 2021 Outstanding Poster Award at the Annual Conference of the European Society of Oncology (ESMO)
- 2021 A joint research grant for clinical bioinformatics research on behalf of the Safra Center for Bioinformatics at Tel Aviv University
- 2018 Outstanding Abstract Award at the annual conference of the Israeli Society for Oncology and Radiotherapy (ISCORT)
- 2017-2025 Forbes magazine’s list of the best oncology doctors
- 2005-2006 The Young Researcher Award of the Israeli Society of Oncology and Radiotherapy (ISCORT)
Scientific Research and Treatment Discoveries of Prof. Yair Bar
Prof. Yair Bar is a prominent figure in thoracic oncology and has made significant contributions to cancer research and treatment. Here are some of his recent discoveries and research highlights:
- Immunotherapy Resistance in Lung Cancer (2024): Prof. Bar’s research lab has been focusing on understanding why some lung cancer patients do not respond to immunotherapy. His team has identified specific biomarkers that predict resistance, which could lead to more personalized treatment plans.
- Cancerous Glucose Metabolism (2022): In 2022, Prof. Bar published a study on the metabolic pathways of lung cancer cells. His research demonstrated how cancer cells alter glucose metabolism to support rapid growth, providing new targets for therapeutic intervention.
- Tumor-Immune System Interactions (2021): Prof. Bar’s work in 2021 explored the interactions between lung tumors and the immune system. His findings have helped to better understand how tumors evade immune detection and have paved the way for new immunotherapy strategies.
- Exhaled Breath Analysis for Lung Cancer Detection (2020): One of his notable projects involved developing a non-invasive method to detect lung cancer through the analysis of exhaled breath. This innovative approach could lead to earlier diagnosis and improved survival rates.
Prof. Bar continues to lead cutting-edge research at Sheba Medical Center and Tel Aviv University, contributing significantly to the field of oncology.
More publications of Prof. Bar: https://pubmed.ncbi.nlm.nih.gov/
